← Back

Biomatter

Lithuania

series-a$18M raisedFreshly fundedBiotech

◆ Total Raised

$18M

◆ Stage

series-a

◆ Location

Lithuania

◆ Links

◆ About Biomatter

A company specializing in custom enzyme design using computational technology and AI to develop enzymes tailored to specific chemical reactions and industrial applications.

◆ Sectors

Biotech

◆ Backing funds on Raise

◆ Funding rounds

12 Nov 2026

Led by Astanor

With UVC Partners, Inventure, Metaplanet

Source ↗

◆ Explore the market

◆ FAQ

What does Biomatter do?

A company specializing in custom enzyme design using computational technology and AI to develop enzymes tailored to specific chemical reactions and industrial applications.

Where is Biomatter based?

Biomatter is based in Lithuania.

How much has Biomatter raised?

Biomatter has raised $18M in tracked funding and is currently at the series-a stage.

Who has invested in Biomatter?

Investors in Biomatter include Metaplanet Ventures and UVC Fund IV.